|
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX ... |
|
20.29% |
|
|
|
|
|
|
|
|
|
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
0 |
0.57% |
|
|
|
|
|
N/A |
0.00% |
33.10% |
25.63% |
|---|
| ABBV |
AbbVie Inc. |
0 |
0.54% |
|
|
|
|
|
N/A |
0.00% |
23.14% |
8.53% |
|---|
| GILD |
Gilead Sciences, Inc. |
0 |
0.54% |
|
|
|
|
|
N/A |
0.00% |
28.60% |
27.35% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
0 |
0.54% |
|
|
|
|
|
N/A |
0.00% |
39.42% |
43.50% |
|---|
| UTHR |
United Therapeutics Corporation |
0 |
0.52% |
|
|
|
|
|
N/A |
0.00% |
35.14% |
12.46% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
0 |
0.51% |
|
|
|
|
|
N/A |
0.00% |
96.18% |
43.24% |
|---|
| AMGN |
Amgen Inc. |
0 |
0.51% |
|
|
|
|
|
N/A |
0.00% |
23.72% |
11.87% |
|---|
| BIIB |
Biogen Inc. |
0 |
0.51% |
|
|
|
|
|
N/A |
0.00% |
33.05% |
17.67% |
|---|
| NTRA |
Natera, Inc. |
0 |
0.51% |
|
|
|
|
|
N/A |
0.00% |
37.21% |
10.51% |
|---|
| INCY |
Incyte Corporation |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
27.79% |
18.79% |
|---|
| INSM |
Insmed Incorporated |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
35.77% |
3.33% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
0 |
0.49% |
|
|
|
|
|
N/A |
0.00% |
38.65% |
25.91% |
|---|
| MRNA |
Moderna, Inc. |
0 |
0.49% |
|
|
|
|
|
N/A |
0.00% |
78.65% |
45.13% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
0.49% |
|
|
|
|
|
N/A |
0.00% |
33.62% |
26.98% |
|---|
| EXAS |
Exact Sciences Corporation |
0 |
0.48% |
|
|
|
|
|
N/A |
0.00% |
45.98% |
28.72% |
|---|
| PCVX |
Vaxcyte, Inc. |
0 |
0.47% |
|
|
|
|
|
N/A |
0.00% |
61.31% |
57.15% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
0 |
0.46% |
|
|
|
|
|
N/A |
0.00% |
27.37% |
15.71% |
|---|
| VKTX |
Viking Therapeutics, Inc. |
0 |
0.44% |
|
|
|
|
|
N/A |
0.00% |
69.67% |
14.07% |
|---|
| TGTX |
TG Therapeutics, Inc. |
0 |
0.42% |
|
|
|
|
|
N/A |
0.00% |
52.25% |
18.27% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
0 |
0.41% |
|
|
|
|
|
N/A |
0.00% |
37.73% |
21.29% |
|---|
| MDGL |
Madrigal Pharmaceuticals, Inc. |
0 |
0.41% |
|
|
|
|
|
N/A |
0.00% |
54.01% |
30.02% |
|---|
| ADMA |
ADMA Biologics, Inc. |
0 |
0.35% |
|
|
|
|
|
N/A |
0.00% |
42.34% |
9.76% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
0 |
0.34% |
|
|
|
|
|
N/A |
0.00% |
37.64% |
23.71% |
|---|
| ROIV |
Roivant Sciences Ltd. |
0 |
0.33% |
|
|
|
|
|
N/A |
0.00% |
69.11% |
96.98% |
|---|
| BPMC |
BLUEPRINT MEDICINES CORP |
|
0.31% |
|
|
|
|
|
|
|
|
|
|---|
| APLS |
Apellis Pharmaceuticals, Inc. |
0 |
0.31% |
|
|
|
|
|
N/A |
0.00% |
52.07% |
16.39% |
|---|
| CYTK |
Cytokinetics, Incorporated |
0 |
0.31% |
|
|
|
|
|
N/A |
0.00% |
54.73% |
17.73% |
|---|
| RVMD |
Revolution Medicines, Inc. |
0 |
0.30% |
|
|
|
|
|
N/A |
0.00% |
46.02% |
33.49% |
|---|
| EXEL |
Exelixis, Inc. |
0 |
0.28% |
|
|
|
|
|
N/A |
0.00% |
29.92% |
21.99% |
|---|
| BBIO |
BridgeBio Pharma, Inc. |
0 |
0.28% |
|
|
|
|
|
N/A |
0.00% |
55.58% |
16.37% |
|---|
| CRSP |
CRISPR Therapeutics AG |
0 |
0.26% |
|
|
|
|
|
N/A |
0.00% |
66.36% |
51.55% |
|---|
| ALKS |
Alkermes plc |
0 |
0.24% |
|
|
|
|
|
N/A |
0.00% |
40.70% |
18.39% |
|---|
| SMMT |
Summit Therapeutics Inc. |
0 |
0.22% |
|
|
|
|
|
N/A |
0.00% |
74.83% |
47.36% |
|---|
| ACLX |
Arcellx, Inc. |
0 |
0.22% |
|
|
|
|
|
N/A |
0.00% |
45.06% |
16.79% |
|---|
| RNA |
Avidity Biosciences, Inc. |
0 |
0.21% |
|
|
|
|
|
N/A |
0.00% |
80.63% |
42.36% |
|---|
| BHVN |
Biohaven Pharmaceutical Holding Company ... |
0 |
0.20% |
|
|
|
|
|
N/A |
0.00% |
125.22% |
72.75% |
|---|
| NUVL |
Nuvalent, Inc. |
0 |
0.19% |
|
|
|
|
|
N/A |
0.00% |
61.35% |
75.83% |
|---|
| TWST |
Twist Bioscience Corporation |
0 |
0.18% |
|
|
|
|
|
N/A |
0.00% |
120.69% |
77.84% |
|---|
| SWTX |
SPRINGWORKS THERAPEUTICS INC |
|
0.18% |
|
|
|
|
|
|
|
|
|
|---|
| RARE |
Ultragenyx Pharmaceutical Inc. |
0 |
0.17% |
|
|
|
|
|
N/A |
0.00% |
45.18% |
4.48% |
|---|
| RXRX |
Recursion Pharmaceuticals, Inc. |
0 |
0.17% |
|
|
|
|
|
N/A |
0.00% |
98.88% |
59.99% |
|---|
| KRYS |
Krystal Biotech, Inc. |
0 |
0.17% |
|
|
|
|
|
N/A |
0.00% |
36.25% |
26.75% |
|---|
| CRNX |
Crinetics Pharmaceuticals, Inc. |
0 |
0.17% |
|
|
|
|
|
N/A |
0.00% |
72.12% |
60.46% |
|---|
| IOVA |
Iovance Biotherapeutics, Inc. |
0 |
0.16% |
|
|
|
|
|
N/A |
0.00% |
186.36% |
27.49% |
|---|
| GERN |
Geron Corporation |
0 |
0.16% |
|
|
|
|
|
N/A |
0.00% |
N/A |
25.63% |
|---|
| DYN |
Dyne Therapeutics, Inc. |
0 |
0.16% |
|
|
|
|
|
N/A |
0.00% |
N/A |
22.71% |
|---|
| CLDX |
Celldex Therapeutics, Inc. |
0 |
0.15% |
|
|
|
|
|
N/A |
0.00% |
50.50% |
23.54% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
0 |
0.15% |
|
|
|
|
|
N/A |
0.00% |
59.65% |
37.12% |
|---|
| VERA |
Vera Therapeutics, Inc. |
0 |
0.14% |
|
|
|
|
|
N/A |
0.00% |
98.28% |
24.69% |
|---|
| VCYT |
Veracyte, Inc. |
0 |
0.14% |
|
|
|
|
|
N/A |
0.00% |
60.74% |
32.45% |
|---|
| PTCT |
PTC Therapeutics, Inc. |
0 |
0.14% |
|
|
|
|
|
N/A |
0.00% |
47.40% |
16.52% |
|---|
| SRRK |
Scholar Rock Holding Corporation |
0 |
0.14% |
|
|
|
|
|
N/A |
0.00% |
128.95% |
35.29% |
|---|
| VRDN |
Viridian Therapeutics, Inc. |
0 |
0.13% |
|
|
|
|
|
N/A |
0.00% |
143.66% |
44.26% |
|---|
| DVAX |
Dynavax Technologies Corporation |
0 |
0.13% |
|
|
|
|
|
N/A |
0.00% |
N/A |
37.93% |
|---|
| FOLD |
Amicus Therapeutics, Inc. |
0 |
0.13% |
|
|
|
|
|
N/A |
0.00% |
93.64% |
98.00% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
94.17% |
49.29% |
|---|
| TVTX |
Travere Therapeutics, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
50.34% |
1.22% |
|---|
| ARQT |
Arcutis Biotherapeutics, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
74.70% |
27.91% |
|---|
| IDYA |
IDEAYA Biosciences, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
88.14% |
36.01% |
|---|
| NVAX |
Novavax, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
82.40% |
32.20% |
|---|
| SLNO |
Soleno Therapeutics, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
90.12% |
36.31% |
|---|
| BEAM |
Beam Therapeutics Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
73.26% |
43.47% |
|---|
| DNLI |
Denali Therapeutics Inc. |
0 |
0.11% |
|
|
|
|
|
N/A |
0.00% |
85.64% |
43.31% |
|---|
| IMVT |
Immunovant, Inc. |
0 |
0.11% |
|
|
|
|
|
N/A |
0.00% |
65.25% |
36.99% |
|---|
| JANX |
Janux Therapeutics, Inc. |
0 |
0.11% |
|
|
|
|
|
N/A |
0.00% |
79.78% |
19.64% |
|---|
| ARDX |
Ardelyx, Inc. |
0 |
0.11% |
|
|
|
|
|
N/A |
0.00% |
55.16% |
34.64% |
|---|
| RYTM |
Rhythm Pharmaceuticals, Inc. |
0 |
0.11% |
|
|
|
|
|
N/A |
0.00% |
52.95% |
26.98% |
|---|
| APGE |
Apogee Therapeutics, Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
275.29% |
3.66% |
|---|
| PRAX |
Praxis Precision Medicines, Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
93.15% |
35.61% |
|---|
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
50.78% |
12.70% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
52.59% |
41.76% |
|---|
| CDNA |
CareDx, Inc |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
173.22% |
27.97% |
|---|
| CPRX |
Catalyst Pharmaceuticals, Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
53.81% |
67.52% |
|---|
| VCEL |
Vericel Corporation |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
64.43% |
62.53% |
|---|
| CGON |
CG Oncology, Inc. Common stock |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
61.84% |
15.49% |
|---|
| AGIO |
Agios Pharmaceuticals, Inc. |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
52.45% |
35.32% |
|---|
| KYMR |
Kymera Therapeutics, Inc. |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
60.00% |
13.77% |
|---|
| SNDX |
Syndax Pharmaceuticals, Inc. |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
63.13% |
3.74% |
|---|
| MYGN |
Myriad Genetics, Inc. |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
59.80% |
16.55% |
|---|
| NRIX |
Nurix Therapeutics, Inc. |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
456.72% |
15.42% |
|---|
| MNKD |
MannKind Corporation |
0 |
0.08% |
|
|
|
|
|
N/A |
0.00% |
620.73% |
34.95% |
|---|
| AKRO |
Akero Therapeutics, Inc. |
0 |
0.08% |
|
|
|
|
|
N/A |
0.00% |
41.17% |
11.80% |
|---|
| DAWN |
Day One Biopharmaceuticals, Inc. |
0 |
0.08% |
|
|
|
|
|
N/A |
0.00% |
511.76% |
50.92% |
|---|
| MIRM |
Mirum Pharmaceuticals, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
32.01% |
17.21% |
|---|
| RCKT |
Rocket Pharmaceuticals, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
179.98% |
66.59% |
|---|
| BCRX |
BioCryst Pharmaceuticals, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
38.80% |
34.46% |
|---|
| SYRE |
Spyre Therapeutics, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
180.72% |
53.13% |
|---|
| CAPR |
Capricor Therapeutics, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
159.37% |
57.12% |
|---|
| IRON |
Disc Medicine, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
34.41% |
9.68% |
|---|
| IBRX |
ImmunityBio, Inc. |
0 |
0.06% |
|
|
|
|
|
N/A |
0.00% |
119.70% |
64.45% |
|---|
| SPRY |
ARS Pharmaceuticals, Inc. |
0 |
0.06% |
|
|
|
|
|
N/A |
0.00% |
124.66% |
20.62% |
|---|
| CDMO |
AVID BIOSERVICES INC |
|
0.05% |
|
|
|
|
|
|
|
|
|
|---|
| HUMA |
Humacyte, Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
87.97% |
30.77% |
|---|
| KURA |
Kura Oncology, Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
112.66% |
30.41% |
|---|
| XNCR |
Xencor, Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
N/A |
66.89% |
|---|
| COGT |
Cogent Biosciences, Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
79.69% |
26.64% |
|---|
| ALT |
Altimmune, Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
87.78% |
17.51% |
|---|
| EBS |
Emergent BioSolutions Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
58.09% |
4.13% |
|---|
| RCUS |
Arcus Biosciences, Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
127.20% |
68.14% |
|---|